Drugs / hematopoietic stem cell infusion
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01372228 | Apr 2011 → Apr 2016 | Hurler syndrome, Hurler-Scheie syndrome, Krabbe disease, Niemann-Pick disease +8 | Talaris Therapeutics Inc. | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | hematopoietic stem cell infusion | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01372228 ↗ |
| Modality | Cell therapy | “hematopoietic stem cell infusion” NCT01372228 ↗ |